Crescentis Capital share news, announcements and annual reports
Crescentis Capital Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 1994
Last close ₹107.05up ₹0.90 (0.85%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹106.15.
30 Oct: open ₹103.10, high ₹108.00, low ₹103.10
52-week range of traded prices to 30 Oct 2026
₹92.95Low, 22 Sep 2026₹144.70High, 19 Feb 2026
- The board meets on 3 Nov 2026 to consider: rights issue of equity shares and rights issue. Every company's board meetings
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹182 Cr2,394th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.40
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- NIMNet interest margin. Net interest income ÷ the average assets that earn interest × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026. Net interest margin in the glossary
- 5.27%
- Cost of fundsCost of funds. Interest paid ÷ the average of what the company pays interest on × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026. Cost of funds in the glossary
- 3.88%
- Credit costCredit cost. What was set aside for loans that may not be repaid ÷ average loans given × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026. Credit cost in the glossary
- 1.41%
- ROAReturn on assets. Profit after tax ÷ average total assets × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. It equals net interest income + other income − operating expenses − provisions + exceptional items − tax + the lines below tax, each on the same base. For the year to Mar 2026. Return on assets in the glossary
- −4.16%
- LeverageAssets per rupee of net worth. Average total assets ÷ average net worth: rupees of assets for each rupee of net worth; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026. Assets per rupee of net worth in the glossary
- 1.15times net worth
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,890
Crescentis Capital board meetings
140 filed, newest first. Page 1 of 3.
Oct 2026
29 Oct · Board meeting
Meeting on 3 Nov 2026: rights issue of equity shares and rights issue
Sep 2026
24 Sep · Board meeting
Meeting on 30 Sep 2026: rights issue of equity shares and rights issue24 Sep · Board meeting
Meeting on 29 Sep 2026: rights issue and rights issue of equity sharesNot held on this date
Aug 2026
7 Aug · Board meeting
Meeting on 13 Aug 2026: quarterly results
May 2026
25 May · Board meeting
Meeting on 29 May 2026: audited results and employees stock option plan
Feb 2026
9 Feb · Board meeting
Meeting on 13 Feb 2026: quarterly results
Nov 2025
6 Nov · Board meeting
Meeting on 12 Nov 2025: quarterly results and employees stock option plan
Aug 2025
7 Aug · Board meeting
Meeting on 13 Aug 2025: employees stock option plan and quarterly results
Jul 2025
Jun 2025
3 Jun · Board meeting
Meeting on 9 Jun 2025: rights issue of equity shares
May 2025
22 May · Board meeting
Meeting on 28 May 2025: rights issue of equity shares, increase in authorised capital, audited results and annual general meeting
Mar 2025
27 Mar · Board meeting
21 Mar · Board meeting
Meeting on 27 Mar 2025: rights issue
Feb 2025
14 Feb · Board meeting
7 Feb · Board meeting
Meeting on 14 Feb 2025: quarterly results
Nov 2024
5 Nov · Board meeting
Oct 2024
29 Oct · Board meeting
Meeting on 5 Nov 2024: quarterly results
Aug 2024
13 Aug · Board meeting
6 Aug · Board meeting
Meeting on 13 Aug 2024: quarterly results
May 2024
29 May · Board meeting
29 May · Board meeting
21 May · Board meeting
Meeting on 29 May 2024: audited results
Apr 2024
5 Apr · Board meeting
Meeting on 5 Apr 2024
Feb 2024
1 Feb · Board meeting
Meeting on 8 Feb 2024: quarterly results
Nov 2023
8 Nov · Board meeting
8 Nov · Board meeting
1 Nov · Board meeting
Meeting on 8 Nov 2023: quarterly results